官方服务：
资源简介：
c, C – ChAdV63.HIVconsv; M – MVA.HIVconsv; D – pSG2.HIVconsv DNA.
应用场景：
创建时间：
2014-07-09
相关数据集
ATN 025 Concomitant Medications [CRF 4] Dataset in Hepatitis B Vaccination in Youth at Adolescent Trials Network Sites: Effectiveness of Two Strategies and Evaluation of Tools to be Used in Future HIV Prevention Trials
Data from Concomitant Medications [CRF 4] Study Description A randomized, single-blinded trial evaluating two licensed vaccine products, Recombivax and Twinrix, given in a two-dose schedule to youth a
NIAID Data Ecosystem70
ATN 076 Monitoring Untoward Effects Form [CRF 96] Dataset in Evaluation of an Intervention to Reduce Preventive Misconception in HIV Vaccine Clinical Trials
Dataset with no observations Study Description A randomized, preliminary proof of concept study evaluating two types of supplemental information that would serve as an adjunct to the traditional infor
NIAID Data Ecosystem30
Dataset from Safety and Immunogenicity Study of GSK Biologicals' Candidate Tuberculosis Vaccine (692342) When Administered to Healthy Infants
This purpose of the study is to assess the safety and immunogenicity of a GSK Biologicals' candidate tuberculosis vaccine (692342) when administered concomitantly with or after the Expanded Programme
NIAID Data Ecosystem20
First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1
BackgroundLive, attenuated viral vectors that express HIV-1 antigens are being investigated as an approach to generating durable immune responses against HIV-1 in humans. We recently developed a repli
Figshare2018-11-14 更新40
Characteristics of HVTN 502 and 503 trial participants.
Data shown are median values (interquartile range) unless otherwise indicated. * At time of sampling § HLA-B*27, B51, B*5701/03, B*5801 and B*8101 Characteristics of HVTN 502 and 503 trial participant
NIAID Data Ecosystem20
